Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats

Acta Anaesthesiol Scand. 2007 Aug;51(7):893-9. doi: 10.1111/j.1399-6576.2007.01353.x.

Abstract

Background: Volatile anesthetics and hypothermia attenuate the inflammatory response. We aimed to compare the anti-inflammatory effects of sevoflurane and mild hypothermia during experimental endotoxemia in the rat.

Methods: Anesthetized, ventilated Sprague-Dawley (SD) rats were randomly treated as follows (n = 6 per group): lipopolysaccharide (LPS) only, animals received LPS [LPS 5 mg/kg, intravenously (i.v.)] with no further treatment. In the LPS-hypothermia group, rats were cooled down to a temperature of 33 degrees C 15 min after LPS-injection (LPS 5 mg/kg i.v.). In animals of the LPS-sevoflurane group, sevoflurane inhalation (1 MAC) was initiated 15 min after induction of endotoxemia. The LPS-sevoflurane-hypothermia group received combined sevoflurane and hypothermia 15 min after induction of endotoxemia. A Sham group served as control without endotoxemia or treatment. After 4 h of endotoxemia, plasma levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and IL-10 were measured. Alveolar macrophages (AM) were ex vivo cultured for nitrite assay.

Results: Inhalation of sevoflurane significantly attenuated plasma levels of TNF-alpha (-60%, P < 0.05) and IL-1beta (-68%, P < 0.05) as compared with the LPS-only group. Hypothermia and its combination with sevoflurane significantly reduced TNF-alpha levels (-46% and -58%, each P < 0.05), but not IL-1beta. Application of mild hypothermia and also its combination with sevoflurane resulted in a significant increase in plasma IL-10 as compared with endotoxemic controls. Nitrite release from AM was found to be significantly suppressed by sevoflurane (-83%), hypothermia (-73%) and by the combination of both (-67%) (P < 0.05, each).

Conclusion: Our data suggest that sevoflurane and mild hypothermia attenuate the inflammatory response during endotoxemia in vivo thus contributing to their beneficial role in clinical organ protection.

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Bronchoalveolar Lavage Fluid / cytology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Endotoxemia / pathology*
  • Hypothermia, Induced*
  • Inflammation Mediators / metabolism
  • Interleukin-10 / blood
  • Interleukin-1beta / blood
  • Lipopolysaccharides / toxicity
  • Macrophages, Alveolar / metabolism
  • Male
  • Methyl Ethers / pharmacology*
  • Nitric Oxide / metabolism
  • Oxygen Consumption / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Sevoflurane
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anesthetics, Inhalation
  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Interleukin-1beta
  • Lipopolysaccharides
  • Methyl Ethers
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Nitric Oxide
  • Sevoflurane